Atlas Trials

An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease

Clinical trial NCT07764146 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07764146
Sponsor
Voyager Therapeutics
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer s Disease
Start date
2026-08-24
Primary completion
2029-04-28
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.